Single cell analysis and live imaging of tissue stem cells and cancer initiating cells
组织干细胞和癌症起始细胞的单细胞分析和实时成像
基本信息
- 批准号:10065416
- 负责人:
- 金额:$ 3.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-03 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:ATAC-seqAddressAffectAgingAnimalsAntigensBasement membraneBindingCell AdhesionCell AgingCell LineageCell divisionCell physiologyCellsChIP-seqChromatinDataEnhancersEventExtracellular MatrixFOXC1 geneFibrinogenGene ExpressionGenesGeneticGenetic ModelsGenetic TranscriptionGenetically Engineered MouseGlioblastomaGoalsHair follicle structureHeterogeneityHomeostasisHumanImageImmuneIn VitroIndividualInstitutesInvestigationKnock-outKnockout MiceKnowledgeLeadLife ExpectancyLinkMaintenanceMalignant NeoplasmsMalignant neoplasm of brainMapsMethodologyMiniaturizationMolecularMutationNF1 geneNatural regenerationNormal tissue morphologyPathway interactionsPatientsPhasePhenocopyPlayPopulationPremature aging syndromeProcessRegulationResearchResearch PersonnelResolutionRoleRunningSkinSystemT-LymphocyteTP53 geneTechniquesTestingTimeTissue imagingTissuesTrainingTranscriptional RegulationWorkanticancer researchbasecancer cellcancer heterogeneitycancer initiationcancer stem cellcareercell behaviorcell motilitycombatcombinatorialcomputerized toolsgenetic manipulationgenome wide association studygenomic toolsimaging systemin vivoinsightintravital imagingmouse modelmoviemultiphoton imagingmutantpathogenprofessorprogramspromoterself-renewalsingle cell analysissingle-cell RNA sequencingspatiotemporalstem cell nichestem cellstissue stem cellstooltranscription factortranscriptomicstumortumor progressiontumorigenesis
项目摘要
Project summary
Integrated transcriptional regulatory circuits govern gene expression programs at the right place and
right time. Mutations in transcription factors contribute to tumorigenesis. Despite the accumulation of
transcription factor profiling, how different transcription factors co-regulate gene expression remains poorly
studied. The research gap leads to the poor resolving power for polygenic conditions, especially cancer. In
addition, the regulation network changes among different cells. In order to systematically and accurately
dissect the transcriptional regulation network in normal tissue homeostasis and tumorigenesis, efforts must be
made to firstly generate genetic models based on the genome-wide association study (GWAS) from human
patients, secondly using advantageous single cell techniques to investigate the regulation of multiple
transcription factors at chromatin, transcription and posttranscription levels in single cells.
For F99 phase of the proposed research, Chi Zhang will continue working on the transcriptional
regulation network of tissue stem cell quiescence, immune privilege and long-term maintenance of stem cell
function. Through genetic knockout of two transcription factors individually and combinatorially in different
cell lineages at different stages, Chi spatiotemporally investigated the functional role in vivo. The established
single cell RNA-seq, ATAC-seq, Cut&Run ChIP-seq also allow Chi to dissect out the regulation network of
Foxc1 and Nfatc1 at molecular level, including promoter enhancer looping, transcription factor binding, open
chromatin dynamics, super enhancer identities, etc. Then using the established multiphoton system, Chi would
be able to visualize the cellular activity of tissue stem cells after genetic manipulation.
For K00 phase of the proposed research, Chi will apply the methodology in the context of glioblastoma.
Considering it as one of the most progressive cancer with life expectancy of 14 to 16 month and existing GWAS
data indicating the mutation of multiple transcription factors in human patients. Using the established
glioblastoma mouse model in Dr. Parada lab, Chi will try to uncover the transcription regulation network of
cancer stem cell, cancer heterogeneity and immune privilege.
At the technical level, the use of genetically engineered mouse models, sophisticated genomic tools
including scATAC-seq/scRNA-seq and live imaging should establish a blueprint for others to link
transcriptional mechanisms to stem cell activities in live animals.
项目摘要
整合的转录调控电路在正确的位置控制基因表达程序,
正是时候转录因子的突变有助于肿瘤发生。尽管积累了
转录因子谱,不同的转录因子如何共同调节基因表达仍然很差
研究了研究差距导致多基因疾病,特别是癌症的分辨能力差。在
此外,不同细胞之间的调节网络也不同。为了系统准确地
剖析正常组织稳态和肿瘤发生中的转录调控网络,
基于人类全基因组关联研究(GWAS),
患者,其次使用有利的单细胞技术来研究多个细胞的调节,
在单个细胞中,在染色质、转录和转录后水平上的转录因子。
对于F99阶段的拟议研究,张驰将继续致力于转录
组织干细胞静止、免疫赦免和干细胞长期维持的调控网络
功能通过基因敲除两种转录因子,
在不同阶段的细胞谱系,Chi时空研究在体内的功能作用。既定
单细胞RNA-seq,ATAC-seq,Cut & Run ChIP-seq也允许Chi解剖出
Foxc1和Nfatc1在分子水平上的研究,包括启动子增强子环,转录因子结合,开放
染色质动力学,超级增强子身份等。然后使用建立的多光子系统,Chi将
能够可视化遗传操作后组织干细胞的细胞活性。
对于拟议研究的K00阶段,Chi将在胶质母细胞瘤的背景下应用该方法。
认为它是最具进展性的癌症之一,预期寿命为14至16个月,现有GWAS
表明人类患者中多种转录因子突变的数据。使用所建立的
在Parada博士实验室的胶质母细胞瘤小鼠模型中,Chi将试图揭示
癌症干细胞、癌症异质性和免疫豁免。
在技术层面,使用基因工程小鼠模型、精密的基因组工具
包括scATAC-seq/scRNA-seq和实时成像应该为其他人建立一个蓝图,
转录机制对活体动物干细胞活动的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chi Zhang其他文献
Chi Zhang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chi Zhang', 18)}}的其他基金
Development of data driven and AI empowered systems biology to study human diseases
数据驱动和人工智能的发展使系统生物学能够研究人类疾病
- 批准号:
10714763 - 财政年份:2023
- 资助金额:
$ 3.81万 - 项目类别:
Chemical-selective real-time laser precision control of biomolecules
生物分子的化学选择性实时激光精密控制
- 批准号:
10810420 - 财政年份:2022
- 资助金额:
$ 3.81万 - 项目类别:
Chemical-selective real-time laser precision control of biomolecules
生物分子的化学选择性实时激光精密控制
- 批准号:
10501038 - 财政年份:2022
- 资助金额:
$ 3.81万 - 项目类别:
Chemical-selective real-time laser precision control of biomolecules
生物分子的化学选择性实时激光精密控制
- 批准号:
10797262 - 财政年份:2022
- 资助金额:
$ 3.81万 - 项目类别:
Chemical-selective real-time laser precision control of biomolecules
生物分子的化学选择性实时激光精密控制
- 批准号:
10693950 - 财政年份:2022
- 资助金额:
$ 3.81万 - 项目类别:
Single cell analysis and live imaging of tissue stem cells and cancer initiating cells
组织干细胞和癌症起始细胞的单细胞分析和实时成像
- 批准号:
10228098 - 财政年份:2020
- 资助金额:
$ 3.81万 - 项目类别:
Perturbation based single cell investigation of tumor micro-environment
基于扰动的肿瘤微环境单细胞研究
- 批准号:
10679051 - 财政年份:2020
- 资助金额:
$ 3.81万 - 项目类别:
Perturbation based single cell investigation of tumor micro-environment
基于扰动的肿瘤微环境单细胞研究
- 批准号:
10634833 - 财政年份:2020
- 资助金额:
$ 3.81万 - 项目类别:
相似国自然基金
基于语义理解的中文地址匹配关键技术研究
- 批准号:
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于众源地址数据的标准地址集智能化构建方法研究
- 批准号:n/a
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
面向空间语义建模与检索的城市地址图模型研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
新型智慧城市地名地址数据融合治理关键技术研究
- 批准号:
- 批准年份:2021
- 资助金额:0.0 万元
- 项目类别:省市级项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
基于SDN的动目标防御网络关键技术研究
- 批准号:61702535
- 批准年份:2017
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 3.81万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 3.81万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 3.81万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 3.81万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 3.81万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 3.81万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 3.81万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 3.81万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 3.81万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 3.81万 - 项目类别:
Research Grant